Mikey, did you lose your job counting pills at Wal-Mart? Do you need help with your trailer rent? Let us know. Thanks, doll.
I'm curious to see if DO hits all the anticipated milestones for the first half of the year. There are 8 if you count the mid 2015 one. January is almost over so that gives him 5 months. Several of those still show "Active, not recruiting" on the clinical trial site. So, he has his work cut out. Hold aside, the SPA seems to be taking forever. Brs. Mauro and Petit have FDA experience so I will assume, other than the FDA asking for more information, the SPA was properly submitted. At this point, it's a waiting game for me.
A dollar and change for a company in PIII with a data readout expected shortly. Hmm... Checking out the latest investor presentation. Pluses I see are low float and two previously controlled PII trials that bested the SOC. Per Morningstar, there is some debt and a bit of fund and institutional ownership. I don't see the management stepping up to buy which is a concern for me as I would think they would add being this close to the readout. More DD for me.
When I talked to IR about two weeks ago, I was told they are still working with the FDA to get the SPA approved.
I saw Boone Pickens also predicted higher oil prices at the year's end but didn't call a price.
"there is no science and there are no hefty profits-- till there is data". So, you're saying having the best one-year OS in cervical cancer ever isn't really data. Okay, well, you must know...